ClinicalTrials.Veeva

Find clinical trials for Multiple Myeloma in Orlando, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Lymphoma
Hematologic Cancer
Leukemia
Cancer
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near Orlando, FL, USA:

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting (POM MM 014)

(LD-Dex) (Cohort B) in subjects with relapsed or refractory multiple myeloma who have received a first or second line treatment of ...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Daratumumab

Phase 2

Celgene
Celgene

Orlando, Florida, United States and 48 other locations

Lenalidomide and Dexamethasone (Rd) maintenance in newly diagnosed multiple myeloma participants for whom ASCT is not planned as in...

Enrolling
Multiple Myeloma
Drug: Cyclophosphamide
Drug: Cilta-cel

Phase 3

Janssen
Janssen

Orlando, Florida, United States and 135 other locations

The purpose of this study is to evaluate the clinical benefit of subcutaneous (SC) daratumumab administered in combination with standard multiple...

Active, not recruiting
Multiple Myeloma
Drug: Daratumumab
Drug: Prednisone

Phase 2

Janssen
Janssen

Orlando, Florida, United States and 63 other locations

The purpose of this study is to compare the efficacy of teclistamab with PVd/Kd.

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Dexamethasone
Drug: Teclistamab

Phase 3

Janssen
Janssen

Orlando, Florida, United States and 193 other locations

of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response...

Enrolling
Multiple Myeloma
Drug: Cyclophosphamide
Biological: idecabtagene vicleucel

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Orlando, Florida, United States and 116 other locations

study is to determine the side effects of treatment of the combination of nivolumab and daratumumab in participants with relapsed/refractory multiple...

Active, not recruiting
Multiple Myeloma
Hodgkin Lymphoma
Biological: Nivolumab
Biological: Lirilumab

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Orlando, Florida, United States and 42 other locations

This is an open label, Phase 1/2, first-in-human, multiple ascending dose, and dose-expansion study of IDP-023 administered as a single agen...

Enrolling
Multiple Myeloma
Refractory Multiple Myeloma
Drug: Fludarabine
Drug: Mesna

Phase 1, Phase 2

Indapta Therapeutics, INC.

Lake Mary, Florida, United States and 7 other locations

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenan...

Enrolling
Multiple Myeloma
Drug: Lenalidomide
Drug: Daratumumab/rHuPH20

Phase 3

SWOG Cancer Research Network

Orlando, Florida, United States and 727 other locations

This is a Phase 1/1b, multicenter, open-label, dose-escalation, and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK),...

Active, not recruiting
Multiple Myeloma
Melanoma
Drug: AB308
Drug: Zimberelimab

Phase 1

Arcus Biosciences
Arcus Biosciences

Orlando, Florida, United States and 28 other locations

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harb...

Enrolling
Multiple Myeloma
Advanced Solid Tumors
Drug: Trastuzumab and Pertuzumab
Drug: Palbociclib

Phase 2

American Society of Clinical Oncology

Orlando, Florida, United States and 160 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems